BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16148555)

  • 1. Host immune responses in hepatitis C virus clearance.
    Barrett S; Sweeney M; Crowe J
    Eur J Gastroenterol Hepatol; 2005 Oct; 17(10):1089-97. PubMed ID: 16148555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance.
    Spada E; Mele A; Berton A; Ruggeri L; Ferrigno L; Garbuglia AR; Perrone MP; Girelli G; Del Porto P; Piccolella E; Mondelli MU; Amoroso P; Cortese R; Nicosia A; Vitelli A; Folgori A
    Gut; 2004 Nov; 53(11):1673-81. PubMed ID: 15479691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HLA class II alleles with hepatitis C virus clearance and persistence in thalassemia patients from Iran.
    Samimi-Rad K; Sadeghi F; Amirzargar A; Eshraghian MR; Alavian SM; Rahimnia R
    J Med Virol; 2015 Sep; 87(9):1565-72. PubMed ID: 25970464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia.
    Cramp ME; Carucci P; Underhill J; Naoumov NV; Williams R; Donaldson PT
    J Hepatol; 1998 Aug; 29(2):207-13. PubMed ID: 9722201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
    Lechmann M; Ihlenfeldt HG; Braunschweiger I; Giers G; Jung G; Matz B; Kaiser R; Sauerbruch T; Spengler U
    Hepatology; 1996 Oct; 24(4):790-5. PubMed ID: 8855177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection: a meta-analysis.
    Hong X; Yu RB; Sun NX; Wang B; Xu YC; Wu GL
    World J Gastroenterol; 2005 Dec; 11(46):7302-7. PubMed ID: 16437632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance and persistence of hepatitis C virus in a Tunisian population: association with HLA class I and class II.
    Ksiaa L; Ayed-Jendoubi S; Sfar I; Gorgi Y; Najjar HA; Abdallah TB; Ayed K
    Viral Immunol; 2007; 20(2):312-9. PubMed ID: 17603847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the peripheral T-Cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response.
    Wang JH; Layden TJ; Eckels DD
    Hum Immunol; 2003 Jul; 64(7):662-73. PubMed ID: 12826368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities.
    Lauer GM; Ouchi K; Chung RT; Nguyen TN; Day CL; Purkis DR; Reiser M; Kim AY; Lucas M; Klenerman P; Walker BD
    J Virol; 2002 Jun; 76(12):6104-13. PubMed ID: 12021343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cellular immune responses induced in the follow-up of interferon-alpha treated patients with chronic hepatitis C may determine the therapy outcome.
    Löhr HF; Gerken G; Roth M; Weyer S; Schlaak JF; Meyer zum Büschenfelde KH
    J Hepatol; 1998 Oct; 29(4):524-32. PubMed ID: 9824260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-hepatitis C virus T-cell immunity in the context of multiple exposures to the virus.
    Pfafferott K; Deshpande P; McKinnon E; Merani S; Lucas A; Heckerman D; Mallal S; John M; Gaudieri S; Lucas M
    PLoS One; 2015; 10(6):e0130420. PubMed ID: 26107956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of IFNL3 and HLA-DPB1 genotype on postpartum control of hepatitis C virus replication and T-cell recovery.
    Honegger JR; Tedesco D; Kohout JA; Prasad MR; Price AA; Lindquist T; Ohmer S; Moore-Clingenpeel M; Grakoui A; Walker CM
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10684-9. PubMed ID: 27601657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class II in a homogeneous population.
    Fanning LJ; Levis J; Kenny-Walsh E; Wynne F; Whelton M; Shanahan F
    Hepatology; 2000 Jun; 31(6):1334-7. PubMed ID: 10827160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel assay for detection of hepatitis C virus-specific effector CD4(+) T cells via co-expression of CD25 and CD134.
    Keoshkerian E; Helbig K; Beard M; Zaunders J; Seddiki N; Kelleher A; Hampartzoumian T; Zekry A; Lloyd AR
    J Immunol Methods; 2012 Jan; 375(1-2):148-58. PubMed ID: 22019644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of a cytotoxic T cell epitope of hepatitis C virus presented by HLA-B*3501 in acute hepatitis.
    Ibe M; Sakaguchi T; Tanaka K; Saito S; Yokota S; Tanaka T; Shimotohno K; Chujoh Y; Shiratori Y; Omata M; Miwa K; Takiguchi M
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1735-44. PubMed ID: 9680137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of hepatitis C-specific CD4+CD25+ regulatory T cells after viral clearance: a mechanism to limit collateral damage?
    Godkin A; Ng WF; Gallagher K; Betts G; Thomas HC; Lechler RI
    J Allergy Clin Immunol; 2008 May; 121(5):1277-1284.e3. PubMed ID: 18355912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source.
    McKiernan SM; Hagan R; Curry M; McDonald GS; Kelly A; Nolan N; Walsh A; Hegarty J; Lawlor E; Kelleher D
    Hepatology; 2004 Jul; 40(1):108-14. PubMed ID: 15239092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection.
    Lauer GM; Barnes E; Lucas M; Timm J; Ouchi K; Kim AY; Day CL; Robbins GK; Casson DR; Reiser M; Dusheiko G; Allen TM; Chung RT; Walker BD; Klenerman P
    Gastroenterology; 2004 Sep; 127(3):924-36. PubMed ID: 15362047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection.
    Harcourt G; Hellier S; Bunce M; Satsangi J; Collier J; Chapman R; Phillips R; Klenerman P
    J Viral Hepat; 2001 May; 8(3):174-9. PubMed ID: 11380794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.